| Structure |
Chemical Name |
CAS |
MF |
 |
Canagliflozin Impurity 69 |
|
|
 |
(+)-epipinoresinol-4-O-β-D-glucoside |
74983-66-7 |
C26H32O11 |
![1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20180702/GIF/CB23049675.gif) |
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C21H24FN3O4 |
 |
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
![2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid](/) |
2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid |
|
|
 |
Cefodizime Impurity D |
|
|
 |
Olaparib Adduct Impurity |
|
|
 |
Thiamine |
6309-04-2 |
C13H20Br2N4OS |
![8-クロロ-5,6-ジヒドロ-5-メチル-6-オキソ-4H-イミダゾ[1,5-a][1,4]ベンゾジアゼピン-3-カルボン酸エチル](/CAS/GIF/78756-33-9.gif) |
8-クロロ-5,6-ジヒドロ-5-メチル-6-オキソ-4H-イミダゾ[1,5-a][1,4]ベンゾジアゼピン-3-カルボン酸エチル |
78756-33-9 |
C15H14ClN3O3 |
 |
Anastrozole Impurity I |
|
|
 |
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
![8-cyclopentyl-5-Methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)aMino)-6-vinylpyrido[2,3-d]pyriMidin-7(8H)-one](/CAS/20150408/GIF/CB72716108.gif) |
8-cyclopentyl-5-Methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)aMino)-6-vinylpyrido[2,3-d]pyriMidin-7(8H)-one |
|
C24H29N7O |
![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/CAS/20211123/GIF/792155-94-3.gif) |
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |
 |
O-デスメチルゲフィチニブ |
847949-49-9 |
C21H22ClFN4O3 |
 |
Ceftriaxone Sodium impurity 3 |
|
|
 |
(E)-1-(3-ピリジル)-3-ジメチルアミノ-2-プロペン-1-オン |
123367-26-0 |
C10H12N2O |
 |
Bimatoprost Impurity 11 |
|
|
 |
1-(4-メトキシフェニル)-2-メチルプロパン-2-アミン |
56490-94-9 |
C11H17NO |
 |
Avatrombopag Impurity 38 |
|
|
![(1R,5R,6R)-5-(1-エチルプロポキシ)-7-アザビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル](/CAS/GIF/204255-02-7.gif) |
(1R,5R,6R)-5-(1-エチルプロポキシ)-7-アザビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル |
204255-02-7 |
C14H23NO3 |
![4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE](/CAS/GIF/29489-04-1.gif) |
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
 |
7'-メチル-2'-プロピル-2,5'-BI-1H-ベンズイミダゾール |
884330-09-0 |
C18H18N4 |
 |
Sulbactam-d5 |
1322880-00-1 |
C8H6D5NO5S |
 |
Brivaracetam Impurity 53 |
|
|
![2-[2-(2-METHOXY-PHENOXY)-ETHYL]-ISOINDOLE-1,3-DIONE](/CAS/GIF/26646-63-9.gif) |
2-[2-(2-METHOXY-PHENOXY)-ETHYL]-ISOINDOLE-1,3-DIONE |
26646-63-9 |
C17H15NO4 |
 |
MetoclopraMide IMpurity F |
38339-95-6 |
C13H20ClN3O2 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
 |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
 |
Thiazolylacetyl glycine oxiMe |
178949-03-6 |
C7H8N4O4S |
![Ethanol, 2-[[2-amino-2-(3-ethoxy-4-methoxyphenyl)ethyl]sulfonyl]-](/CAS/20210305/GIF/2733250-84-3.gif) |
Ethanol, 2-[[2-amino-2-(3-ethoxy-4-methoxyphenyl)ethyl]sulfonyl]- |
2733250-84-3 |
C13H21NO5S |
 |
N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide |
|
C22H23N3O7S2 |
 |
Canagliflozin Impurity 56 |
|
|
 |
Everolimus EP Impurity E |
1237826-25-3 |
C52H79NO14 |
 |
Eltrombopag Impurity 8 |
|
|
 |
Epinastine Impurity 1 HCl |
141342-71-4 |
C15H15N3O2 |
 |
Acyclovir impurity R |
|
|
 |
Sitagliptin EP Impurity B |
1345822-87-8 |
C16H19F5N5O5P |
 |
Apixaban Impurity 13 |
|
|
 |
5,7-ジフルオロクロマン-4-オン |
844648-22-2 |
C9H6F2O2 |
 |
Pramipexole Impurity Z2 |
|
|
 |
Pralatrexate Impurity 16 |
|
|
 |
Loratadine Impurity L |
|
C22H23ClN2O2 |
 |
Febuxostat Impurity 90 |
2646683-37-4 |
|
 |
Tigecycline Impurity 1 |
1138343-10-8 |
C29H38N5O10+ |
![7-[(β-D-グルコピラノシル)オキシ]-4',5-ジヒドロキシ-3',5'-ジメトキシフラボン](//CAS/GIF/32769-01-0.gif) |
7-[(β-D-グルコピラノシル)オキシ]-4',5-ジヒドロキシ-3',5'-ジメトキシフラボン |
32769-01-0 |
C23H24O12 |
 |
((2S,5R)-2-carbamoyl-5-((sulfooxy)amino)piperidine-1-carbonyl)-L-arginine |
|
|
 |
Oseltamivir Impurity 56 |
|
|
 |
Procatero Impurity |
90098-93-4 |
C11H9NO3 |
 |
Oseltamivir Impurity 49 |
|
|
![2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI)](/CAS/20180808/GIF/130609-10-8.gif) |
2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI) |
130609-10-8 |
C12H18NNaO6S |
![(Z)-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylic acid](/CAS/20150408/GIF/1174733-90-4.gif) |
(Z)-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylic acid |
1174733-90-4 |
C10H14N4O6 |
 |
10-ブロモカルバマゼピン |
59690-97-0 |
C15H11BrN2O |
 |
Fexofenadine N-Oxide |
1422515-52-3 |
C32H39NO5 |
 |
Nateglinide Methyl Ester |
105746-47-2 |
C20H29NO3 |
 |
Dapoxetine impurity |
2242008-36-0 |
C28H26O3 |
 |
Oxacillin Sodium Impurity I(EP) |
|
|
 |
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
 |
DexMedetoMidine IMpurity 17 |
|
|
 |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.ClH |
 |
Bortezomib Impurity G Full Set Pre- |
|
|
![sodium 2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-5- hydroxy-4-sulfonatobenzo[d]imidazol-1-ide](/CAS/20200401/GIF/CB84672939.gif) |
sodium 2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-5- hydroxy-4-sulfonatobenzo[d]imidazol-1-ide |
|
C15H13N3Na2O6S2 |
 |
Canagliflozin Impurity 11 |
|
|
 |
Agomelatine Impurity 1 |
|
|
 |
Empagliflozin Impurity 43 |
|
|
 |
Linagliptin Impurity 51 |
|
|
 |
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
 |
Ibrutinib Impurity 2 |
2417548-78-6 |
|
 |
Linagliptin Impurity X |
|
|
 |
Tacrolimus Impurity 5 |
161861-18-3 |
C44H67NO12 |
 |
Axitinib Impurity 3 |
|
|
 |
Tenofovir Impurity 63 |
|
|
 |
1-(4-PIPERIDINYLCARBONYL)-4-PIPERIDINECARBOXYLIC ACID |
96053-48-4 |
C12H20N2O3 |
 |
Tazobactam Impurity B |
158411-82-6 |
C6H11NO3S |
 |
Ezetimibe Impurity 38 |
1701462-59-0 |
C45H58F2N2O5Si2 |
 |
Canagliflozin Impurity 1 |
|
|
 |
Bendamustine Impurity 39 |
|
|
 |
Paxlovid Impurity 18 |
|
|
 |
Clindamycin Impurity 6 |
|
|
 |
SofosBuvir Impurity 53 |
1015255-46-5 |
C20H25FN3O9P |
 |
Etoricoxib Impurity 35 |
855307-79-8 |
C18H13ClN2O2S |
 |
Indacaterol Impurity 12 |
1026461-20-0 |
C22H24N2O3 |
 |
Ebastine IMpurity G |
1429071-65-7 |
C32H39NO3 |
 |
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid |
1714147-47-3 |
C25H36CaFN3O7S |
 |
ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)- |
863329-65-1 |
C24H21FN2O7 |
 |
Cabozantinib impurity 73 |
|
|
 |
(R)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate |
|
C22H23FN2O5 |
 |
Etoposide Impurity 1 |
|
|
 |
Rocuronium bromide Impurity 36 |
|
|
 |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- |
2606144-45-8 |
C16H18N6O |
 |
Linagliptin Impurity 31 |
|
|
 |
Regorafenib Impurity 16 |
|
|
 |
N-Depiperidin-3-amine Linagliptin Dimer |
2253964-98-4 |
C45H44N14O4 |
 |
Fondaparinux sodium impurity 5 |
|
|
 |
Tofacitinib Impurity 81 |
|
|
![(4R,6S)-6-(2-[15N]アミノエチル)-2,2-ジメチル-1,3-ジオキサン-4-酢酸1,1-ジメチルエチル](/CAS/20180629/GIF/CB03956533.gif) |
(4R,6S)-6-(2-[15N]アミノエチル)-2,2-ジメチル-1,3-ジオキサン-4-酢酸1,1-ジメチルエチル |
|
C14H27NO4 |
 |
Dasatinib IMpurity 4 |
|
|
 |
Recombinant Endo Beta-N-Acetylglucosaminidase (ENGASE) |
|
|
 |
Canagliflozin Impurity 57 |
|
|
 |
FeBuxostat Impurity 41 |
2428631-67-6 |
C19H19N3O3S |
 |
(8S,16S,Z)-16-amino-5-(2-aminothiazol-4-yl)-11-imino-2,2-dimethyl-6,9-dioxo-8-((S)-1-(sulfoamino)ethyl)-3-oxa-4,7,10,12-tetraazaheptadec-4-ene-1,17-dioic acid |
|
|